Literature DB >> 2821153

DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders. Induction by anti-DNA antibodies, antihistone antibodies, and antireceptor antibodies.

R M Bennett1, B L Kotzin, M J Merritt.   

Abstract

The ability of sera from patients with SLE and similar connective tissue diseases to induce dysfunction of the receptor for DNA was studied. All SLE and MCTD sera studied resulted in marked inhibition of DNA receptor binding. Furthermore, the sera from a subgroup of patients with other rheumatic diseases and a surprisingly high percentage of asymptomatic relatives of SLE patients exhibited a similar effect. The humoral factors causing this defect were shown to be of at least three reactivities: (a) antibodies to DNA, (b) antibodies to histones, and (c) antibodies to the DNA receptor itself. The reactivity of anti-DNA and antihistone antibodies is dependent upon intact cell-surface DNA, and reconstitution experiments suggest that antihistone antibodies are reactive with histones complexed to this DNA, which in turn is bound to the DNA receptor. Cells with an antibody-induced DNA receptor defect are unable to bind DNA; the subsequent inability to degrade DNA may have important consequences in diseases such as SLE in which DNA-anti-DNA immune complexes are of pathogenetic significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821153      PMCID: PMC2188722          DOI: 10.1084/jem.166.4.850

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

Review 2.  The association of DNA and RNA with membranes.

Authors:  M P Moyer
Journal:  Int Rev Cytol       Date:  1979

3.  Physical properties of cytoplasmic membrane-associated DNA.

Authors:  W Meinke; M R Hall; D A Goldstein; D E Kohne; R A Lerner
Journal:  J Mol Biol       Date:  1973-06-25       Impact factor: 5.469

4.  Use of anti-idiotypic antibodies as cell-surface receptor probes.

Authors:  K Sege; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

5.  Characterization of anti-F(ab')2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies.

Authors:  H Nasu; D S Chia; O Taniguchi; E V Barnett
Journal:  Clin Immunol Immunopathol       Date:  1982-10

6.  Mixed connective tisssue disease: a clinicopathologic study of 20 cases.

Authors:  R M Bennett; D J O'Connell
Journal:  Semin Arthritis Rheum       Date:  1980-08       Impact factor: 5.532

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus.

Authors:  L Raptis; H A Menard
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

9.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.

Authors:  N I Abdou; H Wall; H B Lindsley; J F Halsey; T Suzuki
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Anti-sDNA antibody purified from sera of human patients with systemic lupus erythematosus--i. Purification and characterization.

Authors:  R C Manak; E W Voss
Journal:  Immunochemistry       Date:  1978-09
View more
  15 in total

1.  Idiotypic mimicry of a cell surface DNA receptor: evidence for anti-DNA antibodies being a subset of anti-anti-DNA receptor antibodies.

Authors:  R M Bennett; K A Cornell; M J Merritt; A C Bakke; D Mourich; S H Hefeneider
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

2.  A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex.

Authors:  L Jacob; J P Viard; B Allenet; M F Anin; F B Slama; J Vandekerckhove; J Primo; J Markovits; F Jacob; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 3.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

4.  The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies.

Authors:  K H Sun; W T Liu; S J Tang; C Y Tsai; S C Hsieh; T H Wu; S H Han; C L Yu
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Identification of DNA-binding proteins on human umbilical vein endothelial cell plasma membrane.

Authors:  T M Chan; G Frampton; J S Cameron
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

6.  Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.

Authors:  S Minota; J B Winfield
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 7.  Diversity and origin of rheumatologic autoantibodies.

Authors:  M J Fritzler; M Salazar
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes.

Authors:  D A Bell; B Morrison; P VandenBygaart
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 9.  Pathogenesis of SLE: immunopathology in man.

Authors:  J R Kalden; T H Winkler; M Herrmann; F Krapf
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 10.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.